Global Variability in Children and Adolescent Metabolic Bariatric Surgery Guidelines: A Worldwide IFSO Survey

Juan Pujol-Rafols1, Daniel M Felsenreich2, Júlia Carmona-Maurici3

  • 1Metabolic and Bariatric Surgery Unit (UCOM), Hospital HM Delfos, Barcelona, Spain. juan.pujol.rafols@gmail.com.

Obesity Surgery
|June 11, 2026
PubMed

Insights

Pediatric metabolic and bariatric surgery (MBS) shows global practice variations despite international guidelines. Standardizing criteria and improving access are crucial for equitable care in severe pediatric obesity.

Area of Science:

  • Pediatric Surgery
  • Obesity Medicine
  • Global Health Policy

Background:

  • Pediatric obesity is a significant global health concern.
  • Traditional weight-loss methods are often insufficient for severe pediatric obesity.
  • Metabolic and bariatric surgery (MBS) is an emerging treatment option for this population.

Purpose of the Study:

  • To analyze global variations in pediatric MBS indications, practices, and insurance coverage.
  • To assess adherence to International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) guidelines.
  • To identify disparities in pediatric MBS access across IFSO member countries.

Main Methods:

  • A descriptive survey was administered to IFSO-affiliated national surgical societies.
  • The online questionnaire comprised 17 items on pediatric MBS.
  • Data collected included indications, techniques, referral patterns, and financial coverage.

Main Results:

  • Most responding societies (86.8%) have national guidelines for pediatric MBS.
  • Adherence to IFSO's BMI criteria varied, with some countries using stricter thresholds or limiting MBS to trials.
  • Sleeve gastrectomy is the most common technique; significant regional disparities exist in financial coverage (59.1%).

Conclusions:

  • Substantial global variability exists in pediatric MBS indications and practices, despite IFSO recommendations.
  • Current practices do not uniformly align with international guidelines.
  • Standardization of criteria and enhanced access are necessary for equitable pediatric MBS treatment.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...